Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 609

[358] Matthews DR, Hermansen K, Connolly AA, Gray D, Schmitz O, Clark A, et al. Greater
in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and soma-
tostatin secretory pulses. Endocrinology 1987;120:2272-8.
[359] Surya S, Horowitz JF, Goldenberg N, Sakharova A, Harber M, Cornford AS, et al. The
pattern of growth hormone delivery to peripheral tissues determines insulin-like growth
factor-1 and lipolytic responses in obese subjects. J Clin Endocrinol Metab 2009;94:
2828-34.
[360] Yoshida R, Sakai K, Okano T, Sakurai Y. Pulsatile drug delivery systems using hydro-
gels. Adv Drug Del Rev 1993;11:85-108.
[361] Medlicott NJ, Tucker IJ. Pulsatile release from subcutaneous implants. Adv Drug Del
Rev 1999;38:139-49.
[362] Siegel RA, Pitt CG. A strategy for oscillatory drug release. General scheme and simpli-
fied theory. J Control Release 1995;33:173-88.
[363] Genter P, Berman N, Jacob M, Ipp E. Counterregulatory hormones oscillate during
steady-state hypoglycemia. Am J Physiol 1998;275:E821-9.
[364] Weigle DS, Koerker DJ, Goodner CJ. A model for augmentation of hepatocyte response
to pulsatile glucagon stimuli. Am J Physiol 1985;248:E681-6.
[365] Martin KA, Hall JE, Adams JM. Comparison of exogenous gonadotropins and pulsa-
tile gonadotropin releasing hormone for induction of ovulation in a single hypogonado-
tropic amenorrhea. J Clin Endocrinol Metab 1993;77:125-9.
[366] Ichikawa H, Fukumori Y. Design of nanohydrogel-incorporated microcapsules for
appropriate controlled-release of peptide drugs. Yakugaku Zasshi 2007;127:813-23.
[367] Langer R. Biomaterials in controlled drug delivery: new perspectives from biotechno-
logical advances. Pharm Technol 1989;13:18-30.
[368] Langer R, Siegel R, Brown L, Leong K, Kost J, Edelman E. Controlled release and
magnetically modulated systems for macromolecular drugs. In: Tirrell DA, Donaruma
LG, Turek AB, editors. Macromolecules as drugs and as carriers for biologically active
materials. New York, NY: New York Academy of Sciences; 1985. p. 1-13.
[369] Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev
2001;46:125-48.
[370] Miyata T, Uragami T, Nakamae K. Biomolecule-sensitive hydrogels. Adv Drug Deliv
Rev 2002;54:79-98.
[371] Chen Z, Hua Z, Xu L, Huang Y, Zhao M, Li Y. Protein-responsive imprinted polymers
with specific shrinking and rebinding. J Mol Recognit 2008;21:71-7.
[372] Morais PC, Garg VK, Oliveira AC, Silveira LB, Santos JG, Rodrigues MMA, et al.
Nanoscaled biocompatible magnetic drug-delivery system: preparation and character-
ization. Hyperfine Interact 2009;190:87-93.
[373] Bae YH, Okanko T, Kim SW. Insulin permeation through thermo-sensitive hydrogels.
J Control Release 1989;9:271-9.
[374] Kibat PG, Igari Y, Wheatley MA, Eisen HN, Langer R. Enzymatically activated
microencapsulated liposomes can provide pulsatile drug release. FASEB J 1990;4:
2533-39.
[375] Liu X, Pettway GJ, McCauley LK, Ma PX. Pulsatile release of parathyroid hormone
from an implantable delivery system. Biomaterials 2007;28:4124-31.
[376] Wang L, Liu M, Gao C, Ma L, Cui D. A pH-, thermo-, and glucose-, triple-responsive
hydrogels: synthesis and controlled drug delivery. React Funct Polym 2010;70:159-67.
[377] Taylor MJ, Tanna S, Sahota TS. UV cross-linked dextran methacrylate-concanavalin a
methacrylamide gel materials for self-regulated insulin delivery. Drug Dev Ind Pharm
2008;34:73-82.